Childhood Risk Factors for Developing Substance Dependence
Philadelphia, PA – October 21, 2009 - There is ample evidence for the genetic influence of alcohol dependence, and ongoing studies are actively looking for specific genes that may confer this increased susceptibility. In addition, while it is well-known that individual risk is increased with the number of relatives with alcohol dependence, scientists have not been in a position to identify who among these individuals might have greater or lesser risk.
Biological Psychiatry is now publishing an article in which researchers evaluated and identified childhood risk factors for the development of future substance use disorders (SUD).
Dr. Shirley Hill and her colleagues recruited children with either high or low familial risk for developing alcohol dependence and followed them annually over an eleven-year span. During this time, they repeatedly evaluated a series of thirteen predictors that are thought to influence familial risk, including educational achievement scores, personality variables, self-esteem, and anxiety, along with specific neurobiological variables (P300 amplitude, a brain neuroelectric potential, and postural body sway).
They found that children with increased body sway and reduced P300 amplitude had an 8-fold increase in their likelihood of developing a substance use disorder by young adulthood, indicating that neurobiological variables are among the most important in predicting outcome. “The P300 is a brain signal that is associated with the significance of events in our environment and may reflect an individual’s ability to make optimal use of such information to guide future behavior. It is both interesting and important that the long-term risk for developing alcohol dependence can be connected to this relatively basic feature of brain wiring,” explained Dr. John Krystal, Editor of Biological Psychiatry.
Dr. Hill commented that these results are important “in showing that risk markers for alcohol dependence and other substance use disorders can be identified long before individuals develop symptoms of these disorders. Better and earlier identification of those at highest risk makes it possible to develop targeted intervention/prevention efforts for these children, possibly enabling them to avoid [this] outcome.” In addition, uncovering these childhood risk markers aids in the search for genes associated with the development of substance use disorders.
# # #
Notes to Editors:
The article is “Childhood Risk Factors for Young Adult Substance Dependence Outcome in Offspring from Multiplex Alcohol Dependence Families: A Prospective Study” by Shirley Y. Hill, Stuart R. Steinhauer, Jeannette Locke-Wellman, and Richard Ulrich. The authors are affiliated with the Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Steinhauer is also affiliated with the Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania. The article appears in Biological Psychiatry, Volume 66, Issue 8 (October 15, 2009), published by Elsevier.
The authors’ disclosures of financial and conflicts of interests are available in the article.
John H. Krystal, M.D. is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available at http//journalselsevierhealthcom/webfiles/images/journals/bps/Biological_Psychiatry_Editorial_Disclosures_08_01_09.pdf.
Full text of the article mentioned above is available upon request. Contact Jayne M. Dawkins at firstname.lastname@example.org to obtain a copy or to schedule an interview.
About Biological Psychiatry
This international rapid-publication journal is the official journal of the Society of Biological Psychiatry. It covers a broad range of topics in psychiatric neuroscience and therapeutics. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and treatment of major neuropsychiatric disorders. Full-length and Brief Reports of novel results, Commentaries, Case Studies of unusual significance, and Correspondence and Comments judged to be of high impact to the field are published, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Concise Reviews and Editorials that focus on topics of current research and interest are also published rapidly.
Biological Psychiatry is ranked 4th out of the 101 Psychiatry titles and 14th out of 219 Neurosciences titles on the 2008 ISI Journal Citations Reports® published by Thomson Scientific.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. www.elsevier.com
Jayne M. Dawkins